PRTN3 and rheumatoid arthritis: Apart from non-canonical ACPAs, which can be detected in as many as 16% of ACPA-negative patients by multiplex citrullinated peptide arrays [101], the occurrence of autoantibody responses to other post-translational modified proteins is a well-known phenomenon in RA (Table 1).